Sensitivity towards <scp>HDAC</scp> inhibition is associated with <scp>RTK</scp> / <scp>MAPK</scp> pathway activation in gastric cancer-Reference-Cited by-同舟云学术

Sensitivity towards HDAC inhibition is associated with RTK / MAPK pathway activation in gastric cancer

Published:2022-08-22 Issue:10 Volume:14 Page:
ISSN:1757-4676
Container-title:EMBO Molecular Medicine
language:en
Short-container-title:EMBO Mol Med

Author:

Seidlitz Therese¹^ORCID,Schmäche Tim¹²³⁴^ORCID,Garcίa Fernando⁵^ORCID,Lee Joon Ho¹,Qin Nan⁶,Kochall Susan¹,Fohgrub Juliane¹,Pauck David⁶,Rothe Alexander¹^ORCID,Koo Bon‐Kyoung⁷⁸,Weitz Jürgen¹²³⁴,Remke Marc⁶,Muñoz Javier⁵⁹¹⁰^ORCID,Stange Daniel E¹²³⁴^ORCID

Affiliation:

1. Department of Visceral, Thoracic and Vascular Surgery Medical Faculty and University Hospital Carl Gustav Carus Technische Universität Dresden Dresden Germany

2. National Center for Tumor Diseases (NCT) Dresden Germany

3. German Cancer Research Center (DKFZ) Heidelberg Germany

4. Helmholtz-Zentrum Dresden - Rossendorf (HZDR) Dresden Germany

5. Proteomics Unit, Spanish National Cancer Research Centre (CNIO) Madrid Spain

6. Department of Pediatric Oncology, Hematology, and Clinical Immunology, Medical Faculty University Hospital Düsseldorf Düsseldorf Germany

7. Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA), Vienna Biocenter (VBC) Vienna Austria

8. Center for Genome Engineering, Institute for Basic Science Daejeon Republic of Korea

9. Biocruces Bizkaia Health Research Institute Barakaldo Spain

10. Ikerbasque, Basque Foundation for Science Bilbao Spain

Funder

Deutsche Krebshilfe

European Proteomics Infrastructure Consortium providing access